Second-generation mother-to-child HIV transmission in South Africa is characterized by poor outcomes.


Journal

AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219

Informations de publication

Date de publication:
01 08 2021
Historique:
entrez: 16 7 2021
pubmed: 17 7 2021
medline: 7 8 2021
Statut: ppublish

Résumé

The worldwide incidence of pregnancy for women living with perinatal HIV infection is increasing. Subsequently, there is growing risk of second-generation mother-to-child HIV transmission. The infant clinical outcomes for such a phenomenon have yet to be described. As part of a wider observational study in KwaZulu-Natal, South Africa, six infants with in-utero HIV infection were identified as being born to mothers with perinatal HIV infection. Blood results and clinical data were collected in the first 3 years of life. In two cases, sample availability allowed confirmation by phylogenetic analysis of grandmother-to-mother-to-child HIV transmission. Outcomes were poor in all six cases. All six mothers had difficulty administering twice daily combination antiretroviral therapy to their infants due to difficulties with acceptance, disclosure, poor health and being themselves long-term nonprogressors. Nonnucleoside reverse transcriptase inhibitor-resistant virus was detected in all mothers tested. None of the infants maintained suppression of viraemia on combination antiretroviral therapy. One infant died, and another was lost to follow-up. As the numbers of second-generation mother-to-child transmissions increase, it is important to highlight that this mother-infant dyad represents an extremely vulnerable group. In order for them to survive and thrive, these infants' mothers require their specific needs to be addressed and given intensive support.

Identifiants

pubmed: 34270488
doi: 10.1097/QAD.0000000000002915
pii: 00002030-202108010-00008
pmc: PMC8288499
mid: NIHMS1691280
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1597-1604

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI133673
Pays : United States

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Références

UNAIDS. Start free stay free AIDS free – 2019 report . 2019; Geneva: UNAIDS, Available at: https://www.unaids.org/sites/default/files/media_asset/20190722_UNAIDS_SFSFAF_2019_en.pdf . [Accessed 10 January 2020].
Slogrove A, Sohn AH, Health C, Sciences H, Town C, Africa S. The global epidemiology of adolescents living with HIV: time for more granular data to improve adolescent health outcomes . Curr Opin HIV AIDS 2018; 13:170–178.
Crane S, Sullivan M, Feingold M, Kaufman GE. Successful pregnancy in an adolescent with perinatally acquired human immunodeficiency virus . Obstet Gynecol 1998; 4:711.
Levine AB, Aaron E, Foster J. Pregnancy in perinatally HIV-infected adolescents . J Adolesc Health 2006; 38:765–768.
Brogly SB, Watts DH, Ylitalo N, Franco EL, Seage GR, Oleske J, et al. Reproductive health of adolescent girls perinatally infected with HIV . Am J Public Health 2007; 97:1047–1052.
Williams SF, Keane-Tarchichi MH, Bettica L, Dieudonne A, Bardeguez AD. Pregnancy outcomes in young women with perinatally acquired human immunodeficiency virus-1 . Am J Obstet Gynecol 2009; 200:e149.
Badell ML, Lindsay M. Thirty years later: pregnancies in females perinatally infected with human immunodeficiency virus-1 . AIDS Res Treat 2012; 2012:418630.
Badell ML, Kachikis A, Haddad LB, Nguyen ML, Lindsay M. Comparison of pregnancies between perinatally and sexually HIV-infected women: an observational study at an urban hospital . Infect Dis Obstet Gynecol 2013; 2013:301763.
Patel K, Karalius B, Powis K, Kacanek D, Berman C, Moscicki AB, et al. Trends in postpartum viral load among women living with perinatal HIV infection in the United States . Lancet HIV 2020; 7:E184–E192.
Trahan MJ, Boucher M, Renaud C, Karatzios C, Metras ME, Valois S, et al. Pregnancies among the first generation of survivors of perinatal HIV infection . J Obstet Gynaecol Canada 2020; 42:446–452.
Zorrilla C, Febo I, Ortiz I, Orengo J, Miranda S, Santiago M, et al. Pregnancy in perinatally HIV-infected adolescents and young adults – Puerto Rico . Morb Mortal Wkly Rep 2002; 52:149–151.
Cruz MLS, Cardoso CA, João EC, Gomes IM, Abreu TF, Oliveira RH, et al. Pregnancy in HIV vertically infected adolescents and young women: a new generation of HIV-exposed infants . AIDS 2010; 24:2727–2731.
Lundberg P, Andersson R, Machado ES, da Costa TP, Hofer CB. Pregnancy outcomes in young mothers with perinatally and behaviorally acquired HIV infections in Rio de Janeiro . Braz J Infect Dis 2018; 22:412–417.
Goodenough CJ, Patel K, Van Dyke RB. Is there a higher risk of mother-to-child transmission of HIV among pregnant women with perinatal HIV infection? . Pediatr Infect Dis J 2018; 37:1267–1270.
Millery M, Vazquez S, Walther V, Humphrey N, Schlecht J, Van Devanter N. Pregnancies in perinatally HIV-infected young women and implications for care and service programs . J Assoc Nurses AIDS Care 2012; 23:41–51.
Elgalib A, Hegazi A, Samarawickrama A, Roedling S, Tariq S, Draeger E, et al. Pregnancy in HIV-infected teenagers in London . HIV Med 2011; 12:118–123.
Byrne L, Sconza R, Foster C, Tookey PA, Cortina-Borja M, Thorne C. Pregnancy incidence and outcomes in women with perinatal HIV infection . AIDS 2017; 31:1745–1753.
Kenny J, Williams B, Prime K, Tookey P, Foster C. Pregnancy outcomes in adolescents in the UK and Ireland growing up with HIV . HIV Med 2012; 13:304–308.
Thorne C, Townsend CL, Peckham CS, Newell ML, Tookey PA. Pregnancies in young women with vertically acquired HIV infection in Europe . AIDS 2007; 21:2552–2566.
Calitri C, Gabiano C, Galli L, Chiappini E, Giaquinto C, Buffolano W, et al. The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection . BMC Infect Dis 2014; 14:277.
Prieto LM, McPhee CF, Rojas P, Mazariegos D, Muñoz E, Mellado MJ, et al. Pregnancy outcomes in perinatally HIV-infected young women in Madrid, Spain: 2000–2015 . PLoS One 2017; 12:e0183558.
Chibber R, Khurranna A. Birth outcomes in perinatally HIV-infected adolescents and young adults in Manipur, India: a new frontier . Arch Gynecol Obstet 2005; 271:127–131.
Millar JR, Bengu N, Fillis R, Sprenger K, Ntlantsana V, Vieira VA, et al. High-frequency failure of combination antiretroviral therapy in paediatric HIV infection is associated with unmet maternal nonadherence . EClinMed 2020; 22:100344.
Republic of South Africa National Department of Health. 2019 ART clinical guidelines for the management of HIV in adults, pregnancy, adolescents, children, infants and neonates . 2019; Available at: https://www.knowledgehub.org.za/elibrary/2019-art-clinical-guidelines-management-hiv-adults-pregnancy-adolescents-children-infants . [Accessed 10 January 2020].
Bonsall D, Golubchik T, de Cesare M, Limbada M, Kosloff B, MacIntyre-Cockett G, et al. A comprehensive genomics solution for HIV surveillance and clinical monitoring in a global health setting . Clin Microbiol 2020; 58:e00382-20.
Zhao L, Illingworth CJR. Measurements of intrahost viral diversity require an unbiased diversity metric . Virus Evol 2019; 5:vey041.
Simelela N, Venter WDF. A brief history of South Africa's response to AIDS . S Afr Med J 2014; 104: (3 Suppl 1): 249–251.
Republic of South Africa National Department of Health. National consolidated guidelines: for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults . 2015; Available at: https://sahivsoc.org/Files/ART Guidelines 15052015.pdf . [Accessed 20 February 2020].
Marston M, Becquet R, Zaba B, Moulton LH, Gray G, Coovadia H, et al. Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa . Int J Epidemiol 2011; 40:385–396.
Adland E, Paioni P, Thobakgale C, Laker L, Mori L, Muenchhoff M, et al. Discordant impact of HLA on viral replicative capacity and disease progression in pediatric and adult HIV infection . PLoS Pathog 2015; 11:e1004954.
Muenchhoff M, Adland E, Karimanzira O, Crowther C, Pace M, Csala A, et al. Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection . Sci Transl Med 2016; 8:358ra125.
Hamers RL, Rinke de Wit TF, Holmes CB. HIV drug resistance in low-income and middle-income countries . Lancet HIV 2018; 5:e588–e596.
Gupta RK, Gregson J, Parkin N, Haile-Selassie H, Forero A, Andrade TL, et al. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis . Lancet Infect Dis 2017; 18:346–355.
Pillay S, Bland RM, Lessells RJ, Manasa J, de Oliveira T, Danaviah S. Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort . AIDS Res Ther 2014; 11:3.
Zanoni BC, Archary M, Buchan S, Katz IT, Haberer JE. Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the cresting wave . BMJ Glob Health 2016; 1:e000004.
Goulder P, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, et al. Evolution and transmission of stable CTL escape mutations in HIV infection . Nature 2001; 412:334–338.
Carlson JM, Du VY, Pfeifer N, Bansal A, Tan VYF, Power K, et al. Impact of pre-Adapted HIV transmission . Nat Med 2016; 22:606–613.
Davidson LL, Grigorenko EL, Boivin MJ, Rapa E, Stein A. A focus on adolescence to reduce neurological, mental health and substance-use disability . Nature 2015; 527:S161–S166.
Brady AM, Deighton J, Stansfeld S. Psychiatric outcomes associated with chronic illness in adolescence: a systematic review . J Adolesc 2017; 59:112–123.
Flynn PM, Abrams EJ. Growing up with perinatal HIV . AIDS 2018; 33:597–603.
Abrams EJ, Mellins CA, Bucek A, Dolezal C, Raymond J, Wiznia A, et al. Behavioral health and adult milestones in young adults with perinatal HIV infection or exposure . Pediatrics 2018; 142:e20180938.
Slogrove A, Schomaker M, Davies MA, Williams P, Balkan S, Ben-Farhat J, et al. The epidemiology of adolescents living with perinatally acquired HIV: a cross-region global cohort analysis . PLoS Med 2018; 15:e1002514.
Stein A, Dalton L, Rapa E, Bluebond-Langner M, Hanington L, Stein KF, et al. Communication with children and adolescents about the diagnosis of their own life-threatening condition . Lancet 2019; 393:1150–1163.
Department of Health Province of KwaZulu-Natal. Step by step guide for the management of children and adolescents on ART . 2017; Unpubl – Pers Commun from Dr Moherndran Archary.
Hodgson I, Plummer ML, Konopka SN, Colvin CJ, Jonas E, Albertini J, et al. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women . PLoS One 2014; 9:e111421.
Santamaria EK, Dolezal C, Marhefka SL, Hoffman S, Ahmed Y, Elkington K, et al. Psychosocial implications of HIV serostatus disclosure to youth with perinatally acquired HIV . AIDS Patient Care STDS 2011; 25:257–264.
Bhatia DS, Harrison AD, Kubeka M, Milford C, Kaida A, Bajunirwe F, et al. The role of relationship dynamics and gender inequalities as barriers to HIV-serostatus disclosure: qualitative study among women and men living with HIV in Durban, South Africa . Front Public Health 2017; 5:188.
Visser MJ, Makin JD, Vandormael A, Sikkema KJ, Forsyth BWC. HIV/AIDS stigma in a South African community . AIDS Care 2009; 21:197–206.
Jennewein MF, Abu-Raya B, Jiang Y, Alter G, Marchant A. Transfer of maternal immunity and programming of the newborn immune system . Semin Immunopathol 2017; 39:605–613.
Abrams EJ, Woldesenbet S, Soares Silva J, Coovadia A, Black V, Technau KG, et al. Despite access to antiretrovirals for prevention and treatment, high rates of mortality persist among HIV-infected infants and young children . Pediatr Infect Dis J 2017; 36:595–601.
Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis . Lancet 2004; 364:1236–1243.
Teasdale C, Sogaula N, Yuengling KA, Wang C, Mutiti A, Arpadi S, et al. HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa . J Int AIDS Soc 2018; 21:e25168.
Technau KG, Strehlau R, Patel F, Shiau S, Burke M, Conradie M, et al. 12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study . Lancet HIV 2018; 5:e706–e714.

Auteurs

Jane R Millar (JR)

HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Department of Paediatrics, University of Oxford, Oxford, UK.

Isabella Fatti (I)

Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.

Noxolo Mchunu (N)

Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.

Nomonde Bengu (N)

Umkhuseli Innovation and Research Management, Pietermaritzburg, South Africa.

Nicholas E Grayson (NE)

Department of Paediatrics, University of Oxford, Oxford, UK.
Nuffield Department of Medicine.

Emily Adland (E)

Department of Paediatrics, University of Oxford, Oxford, UK.

David Bonsall (D)

Nuffield Department of Medicine, Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK.

Moherndran Archary (M)

Department of Paediatrics, King Edward VIII Hospital/University of KwaZulu-Natal, Durban, South Africa.

Philippa C Matthews (PC)

Nuffield Department of Medicine.
Department of Microbiology and Infectious Diseases, Oxford University Hospitals NHS Foundation Trust.
Oxford BRC, John Radcliffe Hospital, Oxford, UK.

Thumbi Ndung'u (T)

HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Africa Health Research Institute (AHRI), Durban, South Africa.
Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Max Planck Institute for Infection Biology, Berlin, Germany.
Division of Infection and Immunity, University College London, London, UK.

Philip Goulder (P)

HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.
Department of Paediatrics, University of Oxford, Oxford, UK.
Africa Health Research Institute (AHRI), Durban, South Africa.
Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH